Visalytics
Visalytics
approved EB-2 (NIW)

Hospitalist/Clinical Assistant Professor

Clinical Immunotherapy Medicine · China · 2025-05-13

Processing Time
40 days
Decision Date
2025-05-13
Location
Pennsylvania
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to enhance CAR-T cell therapy for hematological malignancies by integrating laboratory research with patient-centered clinical trials. The work focuses on closing the translational gap to bring immunotherapy discoveries into clinical practice for leukemia and other blood cancers. The goal is to develop therapies that are more precise, responsive, and accessible to patients.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the critical need for advanced blood cancer treatments and CAR-T cell therapy innovation.

2 Well-positioned to Advance the Endeavor Met

The petitioner's academic record, patent, and clinical expertise demonstrate the capacity to lead translational research.

3 Balance of Interests Met

The petitioner's contributions to public health and cancer research outweigh the need for a labor certification.

Why This Petition Was Approved

The petition was approved based on the petitioner's record of 9 peer-reviewed journal articles, 2 abstracts, and 39 total citations. Additional evidence included a granted patent, the completion of at least 25 peer reviews, and research funding from the National Natural Science Foundation of China. The case was supported by expert recommendation letters and demonstrated alignment with national priorities in biomedical innovation.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Patents
Reference Letters Dependent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Pennsylvania 103 days 2023-05-26
The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.
View Case

Research Fellow

Biotechnology · India

WeGreened EB-2 (NIW) approved
Massachusetts 111 days 2023-03-23
The petitioner proposes to continue her research in biomedical sciences, specifically optimizing therapeutic strategies for acute myeloid leukemia by elucidating molecular mechanisms. Her work focuses on identifying leukemia stem cell markers and critical transcription factors to develop advanced treatment strategies for therapy-resistant quiescent stem cells in blood cancer.
View Case

Doctor

Healthcare · India

WeGreened EB-2 (NIW) approved
New York 341 days 2025-05-23
The petitioner proposes to conduct high-quality clinical trials and literature reviews to discover new therapeutics and refine treatment protocols for hematologic malignancies and solid organ cancers. Her work focuses on enrolling patients in trials and synthesizing data on modern treatment approaches to improve care outcomes for patients with serious oncological conditions.
View Case

Scientist

Healthcare · Bangladesh

WeGreened EB-2 (NIW) approved
Japan 126 days 2022-04-15
The petitioner proposes to continue her research on investigating the pathways that regulate healthy and cancerous cells. This work aims to develop new therapeutic drugs and organ transplant technologies, specifically focusing on identifying genetic markers associated with cancerous cell growth and proliferation.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-13.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 40 days
Criteria Met 3 / 3
Evidence Types 8

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist